The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study
Author(s) -
Thomas J. Peto,
Rupam Tripura,
Nou Sanann,
Bipin Adhikari,
James J. Callery,
Mark Droogleever,
Chhouen Heng,
Phaik Yeong Cheah,
Chan Davoeung,
Chea Nguon,
Lorenz von Seidlein,
Arjen M. Dondorp,
Christopher Pell
Publication year - 2018
Publication title -
transactions of the royal society of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 105
eISSN - 1878-3503
pISSN - 0035-9203
DOI - 10.1093/trstmh/try053
Subject(s) - malaria , mass drug administration , incentive , medicine , environmental health , focus group , health facility , socioeconomics , business , immunology , population , marketing , health services , sociology , economics , microeconomics
Mass drug administrations (MDAs) are part of the World Health Organization's Plasmodium falciparum elimination strategy for the Greater Mekong Subregion (GMS). In Cambodia, a 2015-2017 clinical trial evaluated the effectiveness of MDA. This article explores factors that influence the feasibility and acceptability of MDA, including seasonal timing, financial incentives and the delivery model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom